Epic Sciences Stock
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
Sign up today and learn more about Epic Sciences Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Epic Sciences Stock
Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine. Epic is founded on a powerful platform to identify and characterize rare cells including circulating tumor cells ("CTCs"). Epic is working with a number of partners including numerous pharmaceutical companies, major cancer centers, the National Cancer Institute, and the National Institutes of Health.
Funding History
| June 2009 | $2.5M |
|---|---|
| November 2012 | $13.0M |
| July 2014 | $30.0M |
| June 2015 | $15.0M |
| April 2017 | $40.0M |
| September 2018 | $52.0M |
Management
Chief Business Officer and General Counsel
Ian Miller
Chief of Medical Innovation; Head of Translational Research Partnerships
Ryan Dittamore
CSO & Head of Laboratory Operations
Pascal Bamford
Founder
David Nelson
CEO & President
Murali K. Prahalad
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
